PMEL and metastatic neoplasm: Recently, Yuan et al reported low to no expression of MHC class I and II molecules by all of the metastatic tumor samples of one patient pre vaccinated with gp100 and tyrosinase peptides and treated with anti-CTLA-4 Ipilimumab [20].